封面
市場調查報告書
商品編碼
1485297

語音假體設備市場規模- 按產品(留置和非留置語音假體)、閥門類型(Provox 閥門、Blom-Singer 閥門、Groningen 閥門)、最終用途(醫院、門診手術中心)- 全球預測,2024 年- 2032 年

Voice Prosthesis Devices Market Size - By Product (Indwelling & Non-Indwelling Voice Prosthesis), Valve Type (Provox Valve, Blom-Singer Valve, Groningen Valve), End-use (Hospitals, Ambulatory Surgical Centers) - Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於旨在恢復語音能力的創新設備的不斷發展,全球語音義肢設備市場規模在 2024 年至 2032 年間將實現 6.7% 的複合年成長率。這些進步為因喉癌或聲帶麻痺等疾病而面臨發聲挑戰的個人提供了有希望的解決方案。例如,2022 年 4 月,澳洲新創公司 Laronix 正在開發一種仿生設備,採用人工智慧驅動的語音克隆技術來恢復喉切除患者的聲音。這家總部位於昆士蘭的公司率先開發了由人工智慧支援的仿生聲音,旨在為經歷過聲帶切除的人提供言語便利,同時恢復他們獨特而獨特的聲音。

從氣管食道穿刺 (TEP) 閥到電喉設備,市場上正在見證旨在提高說話能力的新技術的激增。隨著這些設備變得更加複雜和易於使用,它們不僅提高了言語障礙人士的生活品質,而且推動了語音義肢設備市場的成長。對改善溝通結果的日益關注推動了持續的研究和創新,塑造了言語復健技術的格局。

整個語音義肢設備產業根據產品、閥門類型、最終用途和地區進行分類。

從 2024 年到 2032 年,非留置發聲器市場將經歷重大發展。與留置義肢不同,非留置裝置不需要頻繁更換或專業干預,方便且具成本效益。此外,材料和設計的進步提高了耐用性和舒適度,進一步推動了市場成長。隨著對高效且患者友善解決方案的需求持續成長,非留置發聲設備的市場有望大幅擴張。

從2024 年到2032 年,Blom Singer 閥門領域的發聲義肢設備市場佔有率將實現顯著的複合年成長率。 這種創新設備為接受過喉切除術的個人提供了可靠的解決方案,使他們能夠恢復言語能力。 Blom-Singer 閥門因其耐用性、易用性和促進聲音產生的有效性而脫穎而出。其獨特的設計和先進的功能使其成為患者和醫療保健專業人員的首選。隨著對高效能、高品質發聲器的需求持續成長,Blom-Singer 閥門仍然是市場擴張的關鍵貢獻者。

歐洲發聲義肢設備市場從 2024 年到 2032 年將呈現出值得稱讚的複合年成長率。該地區的人口老化和喉癌等疾病盛行率的增加加劇了這一需求。此外,醫療技術和報銷政策的進步進一步促進了市場成長。歐洲患者和醫療保健專業人員優先考慮提供耐用性、有效性和改善生活品質的設備。因此,在醫療保健行業不斷變化的需求的推動下,歐洲的語音義肢設備市場正在持續擴張。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 喉癌盛行率增加
      • 日益關注以病人為中心的護理
      • 發聲義肢設備的技術進步
    • 產業陷阱與挑戰
      • 與發聲義肢設備和相關程序相關的高成本
  • 成長潛力分析
  • 監管環境
  • 2023 年定價分析
  • 波特的分析
  • PESTEL分析
  • 報銷場景
  • 未來市場趨勢
  • 缺口分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2018 年 - 2032 年

  • 主要趨勢
  • 留置發聲假體
  • 非留置發聲假體

第 6 章:市場估計與預測:按閥門類型,2018 - 2032 年

  • 主要趨勢
  • 普羅沃克斯閥門
  • 布洛姆辛格閥
  • 格羅寧根閥門

第 7 章:市場估計與預測:按最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 8 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章:公司簡介

  • Andreas Fahl Medizintechnik-Vertrieb GmbH
  • Atos Medical
  • HEIMOMED Heinze GmbH & Co. KG
  • Hood Laboratories
  • ICU Medical, Inc.
  • InHealth Technologies
  • Innaumation Medical Devices Private Limited
  • Luminaud, Inc.
  • Servona GmbH
  • Teleflex Incorporated
簡介目錄
Product Code: 8495

Global Voice Prosthesis Devices Market Size will witness 6.7% CAGR between 2024 and 2032 due to the increasing development of innovative devices aimed at restoring speech capabilities. These advancements offer promising solutions for individuals facing challenges in vocalization due to conditions such as laryngeal cancer or vocal cord paralysis. For instance, in April 2022, Laronix, an Australian start-up, was in the process of creating a bionic device employing AI-driven voice-cloning technology to restore the voices of laryngectomy patients. This Queensland-based company was pioneering the development of an AI-supported bionic voice, aiming to facilitate speech for individuals who have undergone voice box removal while restoring their unique and distinctive voices.

From tracheoesophageal puncture (TEP) valves to electrolarynx devices, the market is witnessing a proliferation of new technologies designed to improve speaking abilities. As these devices become more sophisticated and accessible, they not only enhance the quality of life for individuals with speech impairments but also drive growth in the Voice Prosthesis Devices market. The rising focus on improving communication outcomes fuels ongoing research and innovation, shaping the landscape of speech rehabilitation technologies.

The overall Voice Prosthesis Devices Industry is classified based on the product, valve type, end-use, and region.

The non-indwelling voice prosthesis segment will experience significant progression from 2024 to 2032. These devices offer a minimally invasive solution for individuals who have undergone laryngectomy, allowing them to regain their speech abilities. Unlike indwelling prostheses, non-indwelling devices do not require frequent replacement or professional intervention, offering convenience and cost-effectiveness. Moreover, advancements in materials and design have led to improved durability and comfort, further driving market growth. As the demand for efficient and patient-friendly solutions continues to rise, the market for non-indwelling voice prosthesis devices is poised for significant expansion.

The voice prosthesis devices market share from the Blom Singer valve segment will register a notable CAGR from 2024 to 2032. This innovative device offers a reliable solution for individuals who have undergone laryngectomy, enabling them to restore their speech abilities. The Blom-Singer Valve stands out for its durability, ease of use, and effectiveness in facilitating voice production. Its unique design and advanced features make it a preferred choice among patients and healthcare professionals alike. As the demand for efficient and high-quality voice prostheses continues to grow, the Blom-Singer Valve remains a key contributor to the market expansion.

Europe voice prosthesis devices market will showcase a commendable CAGR from 2024 to 2032. With a focus on healthcare innovation and patient-centered care, European countries are witnessing a growing demand for voice prostheses. The region's aging population and increasing prevalence of conditions such as laryngeal cancer contribute to this demand. Additionally, advancements in medical technology and reimbursement policies further boost market growth. European patients and healthcare professionals prioritize devices that offer durability, effectiveness, and improved quality of life. As a result, the Voice Prosthesis Devices market in Europe is experiencing sustained expansion, driven by the evolving needs of the healthcare sector.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of laryngeal cancer
      • 3.2.1.2 Rising focus on patient-centric care
      • 3.2.1.3 Technological advancements in voice prosthesis devices
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with voice prosthesis devices and related procedures
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Pricing analysis, 2023
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Reimbursement scenario
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Indwelling voice prosthesis
  • 5.3 Non-indwelling voice prosthesis

Chapter 6 Market Estimates and Forecast, By Valve Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Provox valve
  • 6.3 Blom-singer valve
  • 6.4 Groningen valve

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Andreas Fahl Medizintechnik-Vertrieb GmbH
  • 9.2 Atos Medical
  • 9.3 HEIMOMED Heinze GmbH & Co. KG
  • 9.4 Hood Laboratories
  • 9.5 ICU Medical, Inc.
  • 9.6 InHealth Technologies
  • 9.7 Innaumation Medical Devices Private Limited
  • 9.8 Luminaud, Inc.
  • 9.9 Servona GmbH
  • 9.10 Teleflex Incorporated